177 related articles for article (PubMed ID: 33770090)
1. Aspirin desensitization in NSAID-exacerbated respiratory disease and its outcomes in the clinical course of asthma: A systematic review of the literature and meta-analysis.
Eraso I; Sangiovanni S; Morales EI; Fernández-Trujillo L
PLoS One; 2021; 16(3):e0247871. PubMed ID: 33770090
[TBL] [Abstract][Full Text] [Related]
2. Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.
Morales DR; Lipworth BJ; Guthrie B; Jackson C; Donnan PT; Santiago VH
J Allergy Clin Immunol; 2014 Jul; 134(1):40-5. PubMed ID: 24388008
[TBL] [Abstract][Full Text] [Related]
3. NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity.
Morales DR; Guthrie B; Lipworth BJ; Jackson C; Donnan PT; Santiago VH
Allergy; 2015 Jul; 70(7):828-35. PubMed ID: 25855099
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and aspirin desensitization in Thai patients with a suggestive history of NSAID-exacerbated respiratory disease.
Wongsa C; Sompornrattanaphan M; Tantilipikorn P; Thongngarm T
Asian Pac J Allergy Immunol; 2022 Sep; 40(3):247-253. PubMed ID: 31677617
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
Tan JHY; Hsu AAL
Respir Med; 2016 Sep; 118():1-3. PubMed ID: 27578463
[TBL] [Abstract][Full Text] [Related]
6. Aspirin desensitization following endoscopic sinus surgery is effective in patients with nonsteroidal antiinflammatory drug exacerbated respiratory disease.
Aydin Ö; Atmiş EÖ; Anadolu Y; Yorulmaz İ; Çelik GE
J Asthma; 2023 Jun; 60(6):1131-1140. PubMed ID: 36218308
[TBL] [Abstract][Full Text] [Related]
7. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
Berges-Gimeno MP; Simon RA; Stevenson DD
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):474-8. PubMed ID: 12452205
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease in adolescents.
Ertoy Karagol HI; Yilmaz O; Topal E; Ceylan A; Bakirtas A
Int Forum Allergy Rhinol; 2015 May; 5(5):392-8. PubMed ID: 25755210
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis Exploring Sinopulmonary Outcomes of Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
Chaaban MR; Moffatt D; Wright AE; Cowthran JA; Hsu ES; Kuo YF
Otolaryngol Head Neck Surg; 2021 Jan; 164(1):11-18. PubMed ID: 32571140
[TBL] [Abstract][Full Text] [Related]
10. Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
Tyrak KE; Kupryś-Lipińska I; Czarnobilska E; Jakieła B; Pajdzik K; Ćmiel A; Plutecka H; Koziej M; Gawrońska A; Konduracka E; Kuna P; Sanak M; Mastalerz L
Respir Med; 2019 Jun; 152():51-59. PubMed ID: 31128610
[TBL] [Abstract][Full Text] [Related]
11. Identification of phenotypic clusters of nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
Lee HY; Ye YM; Kim SH; Ban GY; Kim SC; Kim JH; Shin YS; Park HS
Allergy; 2017 Apr; 72(4):616-626. PubMed ID: 27805264
[TBL] [Abstract][Full Text] [Related]
12. Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine.
Makowska JS; Olszewska-Ziąber A; Bieńkiewicz B; Lewandowska-Polak A; Kurowski M; Woźniakowski B; Rotkiewicz A; Kowalski ML
Allergy Asthma Proc; 2016 May; 37(3):216-24. PubMed ID: 27178890
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic tests to predict the efficacy of aspirin desensitization in patients with aspirin-exacerbated respiratory diseases; HLA-DQB302.
Esmaeilzadeh H; Nabavi M; Aryan Z; Amirzargar AA
Expert Rev Respir Med; 2015 Oct; 9(5):511-8. PubMed ID: 26366802
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the clinical outcomes of patients with NSAID-exacerbated respiratory disease receiving aspirin or biologicals.
Tuncay G; Damadoglu E; Cihanbeylerden M; Can Bostan O; Kayıkcı H; Özer S; Karakaya G; Kalyoncu AF
J Asthma; 2023 Oct; 60(10):1885-1894. PubMed ID: 36971076
[TBL] [Abstract][Full Text] [Related]
15. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
Jaturapatporn D; Isaac MG; McCleery J; Tabet N
Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
[TBL] [Abstract][Full Text] [Related]
16. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
White AA; Stevenson DD; Simon RA
Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
[TBL] [Abstract][Full Text] [Related]
17. Interventions to improve adherence to inhaled steroids for asthma.
Normansell R; Kew KM; Stovold E
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD012226. PubMed ID: 28417456
[TBL] [Abstract][Full Text] [Related]
18. Natural history and clinical features of aspirin-exacerbated respiratory disease.
Fahrenholz JM
Clin Rev Allergy Immunol; 2003 Apr; 24(2):113-24. PubMed ID: 12668892
[TBL] [Abstract][Full Text] [Related]
19. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases.
Katial RK; Strand M; Prasertsuntarasai T; Leung R; Zheng W; Alam R
J Allergy Clin Immunol; 2010 Oct; 126(4):738-44. PubMed ID: 20728206
[TBL] [Abstract][Full Text] [Related]
20. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
Walters KM; Waldram JD; Woessner KM; White AA
Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
